Cerebain Biotech Corp. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by CLEMONS ERIC, was filed 30 Jun 2014.
Cerebain Biotech Corp.: what insiders have been doing
Cerebain Biotech Corp. is a listed company. Its insiders report their share dealings to SEC (Form 4). Cerebain Biotech Corp. has had no insider filing for more than a year; the last one goes back to 25 September 2018.
Since 2012, the database holds 4 purchases and no sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2011FY ended November 2011 · cache
- 160,000 shares@ US$0.18100.0% of flowCommon StockSEC:0001435164-18-000001:0
- 160,000 shares@ US$0.18100.0% of flowCommon StockSEC:0001435164-18-000002:0
- 150,000 shares@ US$0.2761.6% of flowCommon StockSEC:0001582945-16-000011:0
- 150,000 shares@ US$0.2736.3% of flowCommon StockSEC:0001582945-16-000010:0
- 150,000 shares@ US$0.3040.8% of flowCommon StockSEC:0001582945-16-000010:1
- 380,625 shares@ US$3,806.25Common StockSEC:0001582945-15-000002:0
- 250,000 shares@ US$0.31Common StockSEC:0001582945-15-000002:1
- 48,435 shares@ US$1.50Common StockSEC:0001582945-14-000007:0
- 80,677 shares@ US$1.50Common StockSEC:0001582945-14-000006:0Canonical exit: 31 Mar 2014 (T+90)
- 47,203 shares@ US$1.10Common StockSEC:0001435164-14-000001:0Canonical exit: 14 Sept 2014 (T+90)
- 25,000 shares@ US$1.50Common StockSEC:0001435164-14-000001:1Canonical exit: 14 Sept 2014 (T+90)
- 100,000 sharesCommon StockSEC:0001135432-12-000009:0Canonical exit: 9 May 2012 (T+90)
12 of 12 declarations
About Cerebain Biotech Corp.
Cerebain Biotech Corp. is a company focused on developing innovative technologies for the treatment of neurological disorders. It is listed on NASDAQ.
